Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab

Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab Publisher Pubmed

Darki A¹ ; Masoumi P¹ ; Soleimani A² ; Naser Moghadasi A²

Show Affiliations

1. MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Multiple Sclerosis and Related Disorders Published:2018

Abstract

Natalizumab is among the most effective drugs for controlling multiple sclerosis (MS). The most important side effect of this drug is progressive multifocal leukoencephalopathy, although some other complications are increasingly reported in literature such as meningitis and encephalitis. Here, a patient with MS who has suffered from myocardial infarction (MI) after the injection of natalizumab is introduced. © 2018

Style	Citing Format
MLA	Darki A, et al.. "Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab." Multiple Sclerosis and Related Disorders, vol. 25, no. , 2018, pp. 26-28.
APA	Darki A, Masoumi P, Soleimani A, Naser Moghadasi A (2018). Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab. Multiple Sclerosis and Related Disorders, 25(), 26-28.
Chicago	Darki A, Masoumi P, Soleimani A, Naser Moghadasi A. "Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab." Multiple Sclerosis and Related Disorders 25, no. (2018): 26-28.
Harvard	Darki A et al. (2018) 'Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab', Multiple Sclerosis and Related Disorders, 25(), pp. 26-28.
Vancouver	Darki A, Masoumi P, Soleimani A, Naser Moghadasi A. Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab. Multiple Sclerosis and Related Disorders. 2018;25():26-28.
BibTex	@article{ author = {Darki A and Masoumi P and Soleimani A and Naser Moghadasi A}, title = {Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab}, journal = {Multiple Sclerosis and Related Disorders}, volume = {25}, number = {}, pages = {26-28}, year = {2018} }
RIS	TY - JOUR AU - Darki A AU - Masoumi P AU - Soleimani A AU - Naser Moghadasi A TI - Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab JO - Multiple Sclerosis and Related Disorders VL - 25 IS - SP - 26 EP - 28 PY - 2018 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract